The integration of artificial intelligence into biotechnology has shifted the paradigm from slow, linear discovery to exponential innovation. For founders in the life sciences, AI is no longer just a tool for automation; it is a co-pilot capable of synthesizing vast datasets, optimizing experimental designs, and navigating complex regulatory landscapes.
These prompts have been rigorously tested to ensure high-performance results across all major Large Language Models (LLMs), including ChatGPT, Gemini, Claude, and DeepSeek. While each model possesses distinct architectures—such as DeepSeek’s proficiency in logic and coding or Claude’s strength in nuanced technical writing—the following 10 prompts provide a universal, robust foundation for scaling your biotech venture.
1. Automating Literature Review & Gap Analysis
Best for: Gemini (due to strong information retrieval and large context windows) or ChatGPT.
Founders often need to digest hundreds of papers to identify novel mechanisms. This prompt forces the AI to act as a research assistant, isolating gaps in current CRISPR applications.
Act as a PhD-level Molecular Biologist. I am providing you with the abstracts of [INSERT NUMBER] recent papers on [SPECIFIC GENE/PROTEIN TARGET].
Please synthesize this information to:
1. Identify the consensus view on the mechanism of action.
2. Highlight three specific contradictions or gaps in the current literature.
3. Propose two novel hypotheses for CRISPR-based intervention that address these gaps.
4. Cite the specific papers (by author/title) that support each point.
The Payoff: Drastically reduces the “time-to-insight” by converting hours of reading into a structured strategic analysis of the scientific landscape.
2. Drafting the Series A Technical Pitch
Best for: Claude (for superior tone, structure, and professional nuance).
Translating deep science into an investable narrative is a critical bottleneck. This prompt structures your complex technology into a compelling business case without diluting the science.
Act as a Venture Capitalist specializing in Life Sciences. Review the following technical summary of our drug discovery platform: [INSERT SUMMARY].
Draft a 10-slide pitch deck outline that focuses on:
1. The specific unmet medical need.
2. The "Unfair Advantage" of our specific sequencing technology compared to standard NGS.
3. A roadmap for FDA regulatory milestones.
4. A clear monetization strategy (e.g., licensing vs. pipeline development).
Tone: Authoritative, data-driven, and commercially viable.
The Payoff: Bridges the gap between the lab bench and the boardroom, ensuring your scientific breakthrough is framed as a scalable market opportunity.
3. Simulating FDA Regulatory Obstacles
Best for: ChatGPT (for versatile role-playing) or Gemini.
Anticipating regulatory pushback is cheaper than fixing it later. This prompt simulates a Pre-IND (Investigational New Drug) meeting.
Act as a senior FDA regulatory reviewer for the Center for Biologics Evaluation and Research (CBER). Evaluate a proposed gene therapy targeting [DISEASE] delivered via [VECTOR TYPE, e.g., AAV].
List the top 5 safety concerns you would raise regarding:
1. Off-target effects and genotoxicity.
2. CMC (Chemistry, Manufacturing, and Controls) challenges for this specific vector.
3. Patient selection criteria for Phase 1 trials.
For each concern, suggest a specific mitigation strategy we should include in our briefing packet.
The Payoff: Pre-empts critical compliance failures by stress-testing your development plan against rigorous regulatory standards.
4. Designing sgRNA Libraries for Specificity
Best for: DeepSeek (optimized for logic and technical patterns) or ChatGPT.
While specific bio-informatics tools are used for final design, LLMs are excellent for high-level strategy and parameter setting for CRISPR screens.
Act as a CRISPR Bioinformatics Specialist. I need to design a pooled sgRNA library for a genome-wide knockout screen in [CELL TYPE] to identify resistance mechanisms to [DRUG].
Define the optimal parameters for:
1. Guide coverage per gene (e.g., how many sgRNAs per gene?).
2. Control sequences (non-targeting vs. safe-targeting).
3. Ranking criteria for minimizing off-target effects in this specific cell line.
4. The computational workflow for de-convoluting the sequencing data post-screen.
The Payoff: Establishes a rigorous experimental framework, ensuring your wet-lab experiments yield statistically significant and cleaner data.
5. Optimizing Clinical Trial Protocols
Best for: Claude (for handling large documents and complex constraints).
Patient recruitment and retention are major cost drivers. This prompt helps design a patient-centric protocol.
Act as a Clinical Operations Director. Review the following draft inclusion/exclusion criteria for a Phase 1/2 trial for [INDICATION]: [PASTE CRITERIA].
Analyze this list for:
1. Criteria that are unnecessarily restrictive and will slow down recruitment.
2. Ambiguities that could lead to protocol deviations at clinical sites.
3. Opportunities to use digital biomarkers or remote monitoring to reduce patient burden.
Propose a revised list that maintains safety while maximizing the recruitment pool.
The Payoff: Streamlines trial operations, potentially saving months of recruitment time and reducing the burn rate.
6. Analyzing the Patent Landscape (FTO)
Best for: Gemini (for broader web access and synthesis) or ChatGPT.
Freedom to Operate (FTO) is existential. This prompt helps you perform a preliminary sweep of the IP landscape before engaging expensive counsel.
Act as an IP Strategy Consultant in Biotechnology. We are developing a novel Cas9 variant with [SPECIFIC ATTRIBUTE, e.g., smaller size, higher fidelity].
Conduct a conceptual analysis of the current CRISPR patent landscape involving broad claims by key patent holders (e.g., Broad Institute, UC Berkeley).
1. Identify specific IP "minefields" related to [SPECIFIC ATTRIBUTE].
2. Suggest three strategies for "designing around" existing broad claims.
3. Outline a strategy for building a defensive patent moat around our delivery mechanism.
The Payoff: Provides early warning of IP conflicts and helps shape R&D direction to avoid costly litigation down the road.
7. Automating Lab Workflows & Python Scripting
Best for: DeepSeek (highly capable in code generation) or Claude.
Modern biotech is data-heavy. Founders often need quick scripts to parse sequencing data or automate liquid handlers.
Act as a Computational Biologist. Write a Python script using Biopython or Pandas to:
1. Import a FASTA file containing [NUMBER] DNA sequences.
2. Filter out sequences shorter than [LENGTH] bp or containing ambiguous bases ('N').
3. Translate the remaining DNA sequences into protein.
4. Export the results to a CSV file with columns for 'Sequence ID', 'DNA', and 'Protein'.
Include comments explaining each step of the code for a junior bioinformatician.
The Payoff: Accelerates data processing and creates reusable code assets, reducing reliance on manual data entry or external contractors.
8. Interpreting Complex Multi-Omics Data
Best for: ChatGPT or Gemini.
Synthesizing transcriptomics, proteomics, and genomics data requires high-level pattern recognition.
Act as a Systems Biologist. I have a dataset showing upregulated genes in [TISSUE TYPE] following treatment with our candidate drug. The top 10 upregulated genes are: [LIST GENES].
1. Perform a pathway enrichment analysis (conceptually) to identify which biological processes are likely activated.
2. Cross-reference these genes with known drug-response databases.
3. Hypothesize a mechanism of action that links these expression changes to the observed phenotypic improvement in [SYMPTOM].
The Payoff: Moves beyond raw data lists to biological narrative, helping you understand why a drug is working (or failing) faster.
9. Competitive Market Intelligence
Best for: Gemini (excellent for processing real-time or broad web information) or DeepSeek.
You need to know who else is targeting your indication and with what modality.
Act as a Competitive Intelligence Analyst for the Pharma industry. Analyze the competitive landscape for [DISEASE/INDICATION].
Create a comparison table of the top 3 competitors currently in clinical trials. Compare them based on:
1. Therapeutic Modality (e.g., small molecule, mAb, gene therapy).
2. Stage of Development (Phase 1, 2, or 3).
3. Reported Efficacy Data (if public).
4. Their primary weakness compared to our proposed approach: [DESCRIBE YOUR APPROACH].
The Payoff: Sharpens your differentiation strategy and prepares you for investor questions regarding the competitive landscape.
10. Generating “Blue Sky” Drug Repurposing Ideas
Best for: Claude (great for creative association) or ChatGPT.
Sometimes the fastest route to market is repurposing an existing asset.
Act as a Medicinal Chemist and Pharmacologist. Consider the molecular structure and known targets of the drug [DRUG NAME].
Based on its mechanism of binding to [TARGET PROTEIN], propose three novel therapeutic indications outside of its current use.
For each proposal:
1. Explain the biological rationale.
2. Identify potential off-target toxicity risks in the new indication.
3. Suggest a quick "killer experiment" to validate this hypothesis in vitro.
The Payoff: Unlocks potential hidden value in existing assets and generates creative pivot options for early-stage platforms.
Pro-Tip: Contextual “Few-Shot” Prompting
For the most complex biotech tasks—such as interpreting sequencing anomalies—use “Few-Shot Prompting.” Instead of just asking the AI to analyze data, provide 2 or 3 examples of previous analyses you considered high quality.
Example structure:
“Here is an example of a good mechanism of action analysis: [Example]. Now, perform the same analysis on this new dataset: [New Data].”
This technique anchors the model to your specific standards of scientific rigor and formatting, significantly reducing the need for revisions.
The convergence of biology and code is the defining feature of this era. By mastering these prompts, you are not replacing scientific expertise; you are amplifying it. Treat these AI models as tireless postdoctoral fellows—capable of immense output but requiring your expert direction to produce breakthrough science.